Luc Dirix
Impact in
- Oncology top 0.1%
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
- Cancer Treatment and Pharmacology
- Cancer Cells and Metastasis
- Cancer Research top 0.2%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Papers in
- Oncology 181
- HER2/EGFR in Cancer Research 50
- Cancer Treatment and Pharmacology 47
- Cancer Immunotherapy and Biomarkers 32
- Cancer Cells and Metastasis 29
-
- Advanced Breast Cancer Therapies 34
- Co-authors
- Steven Van Laere (83 shared papers)Peter A. van Dam (58 shared papers)Peter Vermeulen (66 shared papers)Peter Vermeulen (36 shared papers)Ilse Van der Auwera (28 shared papers)Cécile Colpaert (23 shared papers)Eric A. Van Marck (21 shared papers)Gert G. Van den Eynden (22 shared papers)
- Journals
- Journal of Clinical Oncology (47 papers)Cancer Research (39 papers)Annals of Oncology (23 papers)British Journal of Cancer (19 papers)European Journal of Cancer (15 papers)
- Partner nations
- BelgiumUnited StatesUnited Kingdom
In The Last Decade
Luc Dirix
309 papers receiving 14.8k citations
Luc Dirix's Hit Papers
Peers
Comparison fields: 5 of 143
- Oncology 7.9k
- Cancer Research 3.8k
- Pulmonary and Respiratory Medicine 2.7k
- Immunology 1.2k
- Genetics 594
Countries citing papers authored by Luc Dirix
This map shows the geographic impact of Luc Dirix's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luc Dirix with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luc Dirix more than expected).
Fields of papers citing papers by Luc Dirix
This network shows the impact of papers produced by Luc Dirix. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luc Dirix. The network helps show where Luc Dirix may publish in the future.
Co-authors
The 25 scholars most cited alongside Luc Dirix, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 313 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phase III Study of Bevacizumab Plus Docetaxel Compared With Placebo Plus Docetaxel for the First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer Hit paper breakdown → | 2010 | 728 |
| 2 | Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study Hit paper breakdown → | 2017 | 597 |
| 3 | Avelumab in metastatic urothelial carcinoma after platinum failure (JAVELIN Solid Tumor): pooled results from two expansion cohorts of an open-label, phase 1 trial Hit paper breakdown → | 2017 | 442 |
| 4 | 2010 | 415 | |
| 5 | 2007 | 358 | |
| 6 | 2002 | 353 | |
| 7 | 2010 | 350 | |
| 8 | 2001 | 321 | |
| 9 | 2013 | 316 | |
| 10 | 2004 | 302 | |
| 11 | 2000 | 270 | |
| 12 | Vascular integrin alpha(v)beta3: a new prognostic indicator in breast cancer. | 1998 | 253 |
| 13 | 2015 | 248 | |
| 14 | 2008 | 247 | |
| 15 | 2001 | 230 | |
| 16 | 2015 | 201 | |
| 17 | 2004 | 194 | |
| 18 | 2003 | 184 | |
| 19 | 2002 | 171 | |
| 20 | 2008 | 169 |
About Luc Dirix
Luc Dirix is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Surgery, having authored 313 papers that have together received 15.2k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (50 papers), Cancer Treatment and Pharmacology (47 papers), Breast Cancer Treatment Studies (34 papers), Advanced Breast Cancer Therapies (34 papers), Cancer Immunotherapy and Biomarkers (32 papers), Cancer Cells and Metastasis (29 papers), Estrogen and related hormone effects (25 papers) and Cancer Genomics and Diagnostics (21 papers). The work is most often cited by research in Oncology (7.9k citations), Cancer Research (3.8k citations), Pulmonary and Respiratory Medicine (2.7k citations), Immunology (1.2k citations) and Genetics (594 citations). Luc Dirix has collaborated with scholars based in Belgium, United States and United Kingdom. Frequent co-authors include Steven Van Laere, Peter A. van Dam, Peter Vermeulen, Peter Vermeulen, Ilse Van der Auwera, Cécile Colpaert, Eric A. Van Marck, Gert G. Van den Eynden, Eric Van Marck and Ina Benoy. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Annals of Oncology, British Journal of Cancer and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.